Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patients
Circulating MPO levels do not correlate with specific SSc disease manifestations. However, higher MPO values are associated with the presence of metabolic syndrome and an unfavorable lipid profile in patients with this condition.
Authors
- Mónica Renuncio‐García (ORCID: https://orcid.org/0000-0001-8991-3241)
- Iván Ferraz‐Amaro (ORCID: https://orcid.org/0000-0003-0197-5267)
- Santos Castañeda (ORCID: https://orcid.org/0000-0002-7748-853X)
- Miguel Ángel González-Gay (ORCID: https://orcid.org/0000-0002-7924-7406)
- Esther F. Vicente‐Rabaneda (ORCID: https://orcid.org/0000-0001-6823-4194)
- Zena Ibrahim-Achi
- Antonia de Vera-González (ORCID: https://orcid.org/0000-0003-3179-6673)
- J. Gonzalo Ocejo-Vinjals
Institutions
- Universidad de Cantabria (ES)
- Universidad de La Laguna (ES)
- Hospital Universitario de Canarias (ES)
- Hospital Universitario de La Princesa (ES)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-11-12
- DOI
- https://doi.org/10.55563/clinexprheumatol/nuevmp
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00